An interventional study of Feedback Report in Depressive Disorders, Depressive Symptoms and Anxiety Disorders and Symptoms, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-07.
Sponsored by Stanford University · Not applicable, Interventional, and Health services research
This is a demonstration project focused on translating neuroscience insights into clinical practice. The researchers will evaluate how neuroscience assessments may be applied in the clinical setting to help inform care decisions. The aim of the study is to undertake a pragmatic pilot trial to assess whether the inclusion of structured feedback from neuroscience assessments has an effect on improving patient outcomes. The study will investigate how neuroscience assessments can be integrated into and improve clinical care. The impact of sharing information and conclusions from these assessments with psychiatric providers will be explored. Outcomes will include symptoms, social/occupational function and qualify of life.
Exclusion Criteria:
All participants in the study will undergo a comprehensive neuroscience assessment including clinical questionnaires, a structured diagnostic interview, neuropsychological assessment, genetic testing, and structural and functional MRI. Participants randomized to the Feedback Group will have the results of this assessment shared with their psychiatric treatment team before they begin treatment. This data will be used at the full discretion of the treatment team to inform personalized treatment options. All treatment decisions remain up to the treatment providers and patient.
Other: Feedback Report
All participants in the study will undergo a comprehensive neuroscience assessment including clinical questionnaires, a structured diagnostic interview, neuropsychological assessment, genetic testing, and structural and functional MRI. However, participants randomized to the Delayed Feedback Group will not have the results of this assessment shared with their treatment team until the end of their participation in this study (12 weeks).
A report of the data from the comprehensive neuroscience assessment is provided to the patient's care team.
Patient Health Questionnaire (PHQ-9)
A 9-item questionnaire of self-reported symptoms of major depression commonly used in research and routine clinical care
Time frame: 12 weeks
Generalized Anxiety Disorder Questionnaire (GAD-7)
A 7-item questionnaire of self-reported symptoms of generalized anxiety commonly used in research and routine clinical care
Time frame: 12 weeks
Sheehan Disability Scale (SDS) of Social/Occupational Functioning
Level of functioning in social, occupational, and home life domains
Time frame: 12 weeks
Frequency, Intensity, and Burden of Side Effects Ratings (FIBSER)
Burden of side effects from psychiatric medication
Time frame: 12 weeks
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stanford University